Coronavirus disease 2019 (COVID-19) has been shown to impact the cardiovascular system by causing congestive heart failure, arrhythmias, myocarditis, acute coronary syndrome (ACS), or nonischemic cardiomyopathy. The infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggers the overproduction of proinflammatory cytokines, generating systemic inflammation and a procoagulant state that can lead to cardiovascular morbidity and mortality. Symptomatology may not be discrete with presentation of chest pain, dyspnea, and fatigue, so careful consideration should be applied to cardiovascular complications. Serial troponin dosage as well as EKG changes serve as viable prognosis markers. Prompt dissolution of the thrombi will minimize the extent of the myocardial injury.
【저자키워드】 SARS-COV-2 infection, COVID 19, Acute coronary syndrome, multiple thrombi, non-st segment elevation myocardial infarction (nstemi), 【초록키워드】 COVID-19, SARS-CoV-2, Coronavirus disease 2019, coronavirus, Prognosis, fatigue, Infection, cardiovascular system, myocardial injury, Symptomatology, myocarditis, Dyspnea, morbidity and mortality, systemic inflammation, congestive heart failure, Cardiomyopathy, proinflammatory cytokines, Arrhythmias, change, cardiovascular complications, Trigger, chest pain, acute respiratory syndrome, dosage, procoagulant, shown, coronary syndrome, EKG, 【제목키워드】 COVID-19, secondary to, Elevation, segment, setting, Coronary,